Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cn-105 (2 trials)
Cerebral Hemorrhage (Phase 2)
Hemorrhage (Phase 2)
Trials (2 total)
Trial APIs (1 total)